Don Young Park

Dr. Don Young Park


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2026 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
HHHana-Joy E. Hanks
Hana-Joy E. Hanks
MKMichael S. Kim
Michael S. Kim
RLRowen Lin
Rowen Lin
VCVivan Chen
Vivan Chen
ATAndy T. Ton
Andy T. Ton
DPDon Young Park
Don Young Park
Introduction: Mixed reality (MR) technology has emerged as a promising technology to endoscopic spine surgery by enhancing surgeon visualization. This early feasibility study introduces the Apple Vision Pro (Apple Inc., Cupertino, CA) Head Mounted Display (AVP HMD) as an intraoperative visualization tool during biportal endoscopic spine surgeries. The SURG-TLX is an established workload assessment tool specifically tailored for surgical procedures and is a specialized modification of the NASA-TLX, a widely established multidimensional measure for cognitive workload. Methods: Adult patients undergoing biportal endoscopic lumbar surgery using the AVP HMD were prospectively followed. SURG-TLX Scores were recorded immediately after each operation to document the cognitive workload of using the AVP HMD during surgery. Demographics, intraoperative, and postoperative complications were collected and assessed. Patient reported outcomes (PROs) were recorded with visual analogue scores (VAS) Back and Leg pain, as well as Oswestry Disability Index (ODI). Results: Forty patients were included in this study. Patients were followed for 3 months after surgery. The mean age of the population was 62.78 ± 16.12 years, with a BMI of 27.90 ± 5.86, with 47.5% being female. Preoperative average VAS Back score was 5.4 ± 3.26, VAS Leg scores was 6.85 ± 2.43, ODI score was 44% ± 18.67%. Average SURG-TLX score was 22.24 ± 7.46. There were 2 intraoperative dural tears with no clinical sequelae, otherwise there were no perioperative complications. At 3 months follow-up, the average post-operative VAS Back was 2.71 ± 3.29, VAS Leg was 2.11 ± 3.19, and ODI was 21.0% ± 22.74, which were significant reductions as compared to the preoperative scores ( p < 0.05). Conclusion: This early feasibility study introduced the use of the AVP HMD during biportal endoscopic spine surgeries and showed that the AVP HDM did not increase the operating surgeon's perceived cognitive workload. The intraoperative use of AVP HMD did not worsen early clinical outcomes and did not increase the risk of complications. We describe the feasibility of incorporating MR technology such as the Apple Vision Pro for surgical visualization during endoscopic spine surgery.

14 July 2026 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
HHHana-Joy Hanks
Hana-Joy Hanks
VCVivian Chen
Vivian Chen
CCCaleb Choi
Caleb Choi
JHJason Horowitz
Jason Horowitz
JHJung-Woo Hur
Jung-Woo Hur
DPDon Young Park
Don Young Park
The use of mixed reality (MR) in endoscopic spine surgery has recently been introduced, promising to enhance visualization, improve workflow, and support intraoperative decision-making. The successful use of the Apple Vision Pro (AVP) MR headset has recently been documented during biportal endoscopic spine surgery. To our knowledge, this case represents the first use of MR technology as an adjunct to biportal endoscopic spine fusion. An 81-year-old male with a history of lumbar stenosis and Grade 1 spondylolisthesis at level 4-5 presented with progressively worsening radicular pain refractory to conservative measures. Based on the clinical findings, the patient underwent a transforaminal lumbar interbody fusion (TLIF) via a biportal endoscopic approach. The procedure included endoscopic laminotomy, bilateral decompression, facetectomy, placement of an interbody cage with bone grafting, and posterior spinal instrumentation and fusion. Throughout the case, the operating surgeon wore the AVP MR Headset, which virtually displayed a live endoscopic view, over the real environment without obstructing the surgical field. The AVP consolidated the endoscopic feed directly into the surgeon's line of sight, eliminating the need to shift gaze between the operative field and external monitors and supporting a more ergonomic, streamlined operative workflow. The patient demonstrated complete resolution of radicular leg pain (VAS Leg 7 → 0) and marked functional recovery (ODI 14% → 2%) by two months postoperatively, with no intraoperative or postoperative complications, and these improvements were maintained through the seven-month follow-up. This case demonstrates the feasibility of using MR as an adjunct to biportal endoscopic lumbar fusion without observed complications. The AVP HMD provided an integrated, line-of-sight visualization platform that reduced reliance on external monitors and supported ergonomic surgical performance. Further investigation is needed to evaluate its effect on surgical efficiency and long-term patient outcomes.

31 October 2024 in Journal of Minimally Invasive Spine Surgery and Technique
Verified
Journal Article
Open access
PDF file
RORafael Garcia de Oliveira
Rafael Garcia de Oliveira
DPDon Young Park
Don Young Park
Unilateral biportal endoscopy (UBE) can be used to treat common lumbar pathologies, such as synovial facet cysts, foraminal disc herniations, and foraminal stenosis via a contralateral sublaminar approach. Due to the ultra-minimally invasive technique, UBE can reduce damage to anatomical structures, thereby reducing postoperative pain and allowing faster recovery. The patient is placed prone on a Wilson frame or bolsters. Fluoroscopy is used to identify the midline and medial pedicle line in the anterior-posterior projection. Spinal needles can aid to identifying portals’ trajectory in the lateral fluoroscopic projection. The procedure is performed via 2 separate portal incisions. The endoscope is introduced through the viewing portal and the surgical instruments through the working portal. Soft tissue dissector is used to create a working area over the spinous process-lamina junction. Bony shaving and drilling start at the target area and continue medially underneath the base of the spinous process until the midline and contralateral ligamentum flavum are identified. Contralateral ligamentum flavum is excised, exposing thecontralateral thecal sac, traversing nerve root, and lateral recess. The contralateral disc space, annulus, and superior articulating process are then identified and the offending pathology can be addressed under direct visualization. Meticulous hemostasis and close attention to outflow should be maintained to reduce the risk of complications. The steps of this procedure closely resemble those of traditional microscopic “over-the-top” techniques, including the surgical instruments used through the working portal. In this video, authors present the surgical technique of the contralateral sublaminar approach in the lumbar spine with UBE.

8 October 2025
Verified
Book Chapter
Closed access
PDF file
MKMin-Seok Kang
Min-Seok Kang
WLWoo Myung Lee
Woo Myung Lee
DCDae-Jung Choi
Dae-Jung Choi
HPHyun-Jin Park
Hyun-Jin Park
DPDon Young Park
Don Young Park

12 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SYShahabeddin Yazdanpanah
Shahabeddin Yazdanpanah
HHHana-Joy E. Hanks
Hana-Joy E. Hanks
CGCarla Guedikian
Carla Guedikian
JDJade Dai
Jade Dai
RLRowen Lin
Rowen Lin
DPDon Young Park
Don Young Park
Background: Biportal endoscopic decompression for lumbar spinal stenosis (LSS) may facilitate rapid recovery, yet early minimal clinically important difference (MCID) achievement across pathology-relevant patient-reported outcome measures (PROMs) here remains insufficiently characterized. Accordingly, this study evaluates early (six-week) MCID achievement and associated factors following biportal endoscopic decompression for LSS to supplement surgeon comprehension and patient expectation-setting. Methods: A prospectively maintained, single-center/surgeon database was retrospectively queried (2021–2026) for adult patients undergoing biportal endoscopic decompression without fusion for LSS-only indications. Cases were excluded based on factors such as missing data, complicating etiologies/procedures, or insufficient follow-up. The primary outcome was literature-anchored MCID achievement, defined as an improvement of ≥2 points in the visual analog scale (VAS)-back and VAS-leg PROMs, and ≥14.9 points in the Oswestry Disability Index (ODI). Statistics included paired comparisons, exploratory multivariable logistic regressions with odds ratios (ORs), sensitivity analyses, and subgroup examinations. Results: Ninety-nine patients were included (mean age = 70.0 ± 10.0 years; body mass index [BMI] = 27.2 ± 5.1 kg/m2; follow-up = 6 ± 0 weeks; 53.5% male). VAS-back improved from 6.1 ± 2.8 to 2.0 ± 2.1, VAS-leg from 6.9 ± 2.4 to 1.4 ± 2.1, and ODI from 42.9 ± 18.6 to 21.5 ± 15.1 (all p < 0.001). Six-week MCID achievement rates were 78.8%, 88.9%, and 63.6%, respectively, with significant pairwise differences (all corrected p < 0.05). Best-case/worst-case exclusion sensitivity analyses yielded achievement ranges of 60.3–83.3% for VAS-back, 67.3–90.4% for VAS-leg, and 46.2–71.8% for ODI. Higher preoperative VAS-back (odds ratio [OR] = 1.810) and ODI (OR = 1.183) were associated with respective MCID achievement. Male sex increased (OR = 4.727) and higher BMI decreased (OR = 0.859) odds of ODI-MCID achievement (both corrected p < 0.05), though findings were statistically limited. In the subgroup with postoperative radiculitis (23.2%), which is known to affect recovery and its perception, lower six-week ODI-MCID achievement was observed (43.5% versus 69.7%, p = 0.022). Conclusions: Biportal endoscopic decompression for LSS was associated with substantial six-week MCID achievement rates, with the highest achievement rate observed for VAS-leg. While baseline symptom severity was associated with MCID achievement, these relationships warrant cautious interpretation given the use of absolute change thresholds. These findings may help to inform patient counseling and early postoperative expectation-setting.

12 October 2026 in Spine Open
Verified
Journal Article
Open access
MRMelissa Romoff
Melissa Romoff
SYShahabeddin Yazdanpanah
Shahabeddin Yazdanpanah
Ryan BeyerRyan Beyer
Ryan Beyer
ACArthur Wesley Cowman
Arthur Wesley Cowman
ETEmily Tse
Emily Tse
EMEmily S Mills
Emily S Mills
Study Design: Retrospective propensity score-matched cohort study. Objective: To evaluate the association between preoperative gabapentinoid use postoperative pseudoarthrosis, reoperation, and medical complications following adult spinal deformity (ASD) surgery. Summary of Background Data: Gabapentinoids are increasingly prescribed for neuropathic and radicular pain and have demonstrated inhibitory effects on bone metabolism and spinal fusion formation in preclinical models. While prior studies have examined chronic gabapentinoid use in short-segment lumbar fusion, no study has evaluated their impact in ASD surgery, where construct length and baseline pseudoarthrosis are substantially greater. Materials and Methods: Adult patients undergoing ASD correction between 2015 and 2022 were identified using the TriNetX Research Network. Patients with preoperative gabapentinoid prescription within 90 days before surgery were compared with nonusers. Exclusion criteria included trauma, neoplasm, infection, prior fusion, revision surgery, and preoperative opioid use. One-to-one propensity score matching was performed on demographics, comorbidities, and medication use. Primary outcomes included pseudoarthrosis and reoperation at one-year, two-year, and three-year follow-up. Secondary outcomes included 90-day medical complications, including venous thromboembolism, surgical site infection, acute kidney injury, pneumonia, stroke, and myocardial infarction. Results: After propensity score matching, 477 gabapentinoid users were matched to 477 nonusers. Baseline demographics and surgical complexity were well balanced between cohorts. No significant differences were observed in 90-day medical complications or reoperation rates at any time point. However, preoperative gabapentinoid use was associated with significantly increased pseudoarthrosis rates at all follow-up intervals. Pseudoarthrosis occurred in 18.18% versus 9.70% of patients at one year and 23.08% versus 11.74% at three years among gabapentinoid users versus nonusers, respectively (all P <0.0001). Conclusion: Preoperative gabapentinoid use was associated with an approximately two-fold increased risk of pseudoarthrosis following ASD surgery without corresponding increases in perioperative complications or reoperation. These findings suggest gabapentinoid exposure may represent an underrecognized modifiable risk factor for failed fusion in ASD surgery and warrants prospective investigation.